Subscribe to our newsletter to receive the latest product updates and special offers

Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#21 / 62 Total
TCON - TRACON Pharmaceuticals Inc - Stock Price Chart
TickerTCON [NASD]
CompanyTRACON Pharmaceuticals Inc
CountryUSA
IndustryBiotechnology
Market Cap3.89MEPS (ttm)0.65
P/E2.24EPS this Y-89.70%
Forward P/E-EPS next Y31.39%
PEG-EPS past 5Y61.51%
P/S0.32EPS next 5Y-
P/B-EPS Q/Q81.52%
Dividend-Sales Q/Q-
Insider Own7.89%Inst Own10.60%
Insider Trans0.00%Inst Trans-0.85%
Short Float6.20%EarningsMay 14/a
Analyst Recom1.67Target Price37.50
Avg Volume272.08K52W Range1.51 - 14.75
TRACON Pharmaceuticals, Inc. engages in the development and commercialization of targeted therapies for cancer, and ophthalmic and fibrotic diseases. Its products include TRC105, an anti-endoglin antibody for the treatment of solid tumor types, TRC205 created for the treatment of fibrotic diseases, and TRC102, a small molecule that is in clinical development made for lung cancer and glioblastoma. The company was founded in October 2004 and is headquartered in San Diego, CA.
VEEE - Twin Vee PowerCats Co - Stock Price Chart
TickerVEEE [NASD]
CompanyTwin Vee PowerCats Co
CountryUSA
IndustryRecreational Vehicles
Market Cap6.09MEPS (ttm)-0.81
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-103.79%
P/S0.20EPS next 5Y-
P/B0.27EPS Q/Q-44.45%
Dividend-Sales Q/Q-40.56%
Insider Own34.78%Inst Own14.90%
Insider Trans0.00%Inst Trans233.06%
Short Float0.19%EarningsMay 15/b
Analyst Recom1.00Target Price8.00
Avg Volume19.66K52W Range0.64 - 2.39
Twin Vee PowerCats Co. engages in the design, manufacture, and sale of recreational and commercial power catamaran boats. The firm is focused on designing and developing its products under the ELECTRA Power Sports brand. It operates through the following segments: Gas-Powered Boats, Electric Boat and Development, and Franchise. The Gas-Powered Boats segment manufactures boats that use fuel. The Electric Boat and Development segment designs fully electric boats through Forza X1 Inc. The Franchise segment deals with developing a standard product offering that is sold for franchise. The company was founded by Roger Dunshee in 1996 and is headquartered in Fort Pierce, FL.
SEEL - Seelos Therapeutics Inc - Stock Price Chart
TickerSEEL [NASD]
CompanySeelos Therapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap32.85MEPS (ttm)-42.75
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y62.30%
P/S16.67EPS next 5Y-
P/B-EPS Q/Q94.28%
Dividend-Sales Q/Q-28.34%
Insider Own8.70%Inst Own13.10%
Insider Trans11.73%Inst Trans-46.15%
Short Float0.82%Earnings-
Analyst Recom1.00Target Price32.00
Avg Volume63.36K52W Range1.92 - 398.40
Seelos Therapeutics, Inc. is a clinical-stage biopharmaceutical company. It engages in the development of products that address significant unmet needs in Central Nervous System (CNS) disorders and other rare disorders. The company was founded by Raj Mehra in 1987 and is headquartered in New York, NY.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Mehra RajSee RemarksDec 01 '23Buy1.3275,75799,999185,142Dec 01 04:16 PM
Golembiewski Michael JosephChief Financial OfficerNov 30 '23Buy1.2183,000100,22286,450Dec 01 04:16 PM
ZPTA - Zapata Computing Holdings Inc. - Stock Price Chart
TickerZPTA [NASD]
CompanyZapata Computing Holdings Inc.
CountryUSA
IndustrySoftware - Infrastructure
Market Cap27.69MEPS (ttm)-4.21
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S22.70EPS next 5Y-
P/B-EPS Q/Q-44077.42%
Dividend-Sales Q/Q-
Insider Own37.49%Inst Own7.01%
Insider Trans0.00%Inst Trans6.72%
Short Float2.61%Earnings-
Analyst Recom-Target Price-
Avg Volume1.17M52W Range0.90 - 18.50
Zapata Computing Holdings, Inc. operates as a generative AI company. It provides data science and engineering techniques for solutions on an industrial scale. The company was founded by Christopher Savoie, Alan Aspuru-Guzik, Yudong Cao, Jonathan Olson, Peter Johnson, and Jonathan Romero-Fontalvo in 2017 and is headquartered in Boston, MA.
BPTH - Bio-Path Holdings Inc - Stock Price Chart
TickerBPTH [NASD]
CompanyBio-Path Holdings Inc
CountryUSA
IndustryBiotechnology
Market Cap3.25MEPS (ttm)-27.34
P/E-EPS this Y71.22%
Forward P/E-EPS next Y17.36%
PEG-EPS past 5Y34.89%
P/S-EPS next 5Y-
P/B-EPS Q/Q63.17%
Dividend-Sales Q/Q-
Insider Own0.23%Inst Own23.89%
Insider Trans0.00%Inst Trans112.18%
Short Float2.84%EarningsMay 15/b
Analyst Recom1.00Target Price20.00
Avg Volume1.47M52W Range2.08 - 44.80
Bio-Path Holdings, Inc. is a biotechnology company, which engages in the development of therapies for acute myeloid leukemia (AML) and chronic myeloid leukemia (CML). Its product pipeline includes Prexigebersen, BP1001-A, BP1002, and BP1003. The company was founded by Peter H. Nielsen, Douglas P. Morris, Gabriel Lopez-Berestein and Ana Tari Ashizawa on May 10, 2007 and is headquartered in Bellaire, TX.
AKTS - Akoustis Technologies Inc - Stock Price Chart
TickerAKTS [NASD, RUT]
CompanyAkoustis Technologies Inc
CountryUSA
IndustryCommunication Equipment
Market Cap37.49MEPS (ttm)-1.00
P/E-EPS this Y22.95%
Forward P/E-EPS next Y40.71%
PEG-EPS past 5Y0.80%
P/S1.26EPS next 5Y-
P/B0.89EPS Q/Q-11.97%
Dividend-Sales Q/Q2.09%
Insider Own5.49%Inst Own39.59%
Insider Trans38.05%Inst Trans-2.20%
Short Float10.69%EarningsMay 13/b
Analyst Recom1.80Target Price1.35
Avg Volume643.31K52W Range0.39 - 3.57
Akoustis Technologies, Inc. is a filter solutions company, which engages in the development, design, and manufacture of radio frequency (RF) filter products. It operates through the Foundry Fabrication Services and RF Filters segments. The Foundry Fabrication Services segment is composed of engineering review services and STC-MEMS foundry services. The RF Filters segment includes amplifier and filter product sales, and grant revenue. The company was founded by Jeffrey B. Shealy in 2014 and is headquartered in Huntersville, NC.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Shealy Jeffrey B.Chief Executive OfficerJan 29 '24Buy0.501,310,000655,0002,222,775Jan 31 06:39 PM
Aichele DavidEVP of Business DevelopmentJan 29 '24Buy0.5080,00040,000334,622Jan 31 06:39 PM
Boller KennethCFOJan 29 '24Buy0.5060,00030,000214,957Jan 31 06:39 PM
Geiss ArthurDirectorJan 29 '24Buy0.5050,00025,000415,924Jan 31 06:40 PM
Aichele DavidEVP of Business DevelopmentDec 18 '23Sale0.721,5001,083254,622Dec 20 05:03 PM
CNTG - Centogene NV - Stock Price Chart
TickerCNTG [NASD]
CompanyCentogene NV
CountryGermany
IndustryDiagnostics & Research
Market Cap10.31MEPS (ttm)-
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-32.60%
P/S-EPS next 5Y-
P/B-EPS Q/Q-13.12%
Dividend-Sales Q/Q-80.94%
Insider Own57.02%Inst Own8.96%
Insider Trans0.00%Inst Trans-0.67%
Short Float0.33%Earnings-
Analyst Recom1.00Target Price1.50
Avg Volume146.82K52W Range0.36 - 1.98
Centogene NV is a commercial-stage company, which focuses on rare diseases that transform real-world clinical and genetic data into actionable information for patients, physicians, and pharmaceutical companies. It operates through the following segments: Pharmaceutical, Diagnostics, and Corporate. The Pharmaceutical segment provides solutions to pharmaceutical partners, including target discovery, early patient recruitment and identification, epidemiological insights, and biomarker discovery. The Diagnostics segment offers genetic sequencing and diagnostics services to clients, who are typically physicians, laboratories, or hospitals, either directly or through distributors. The Other segment covers COVID-19 testing services to clients. The company was founded by Arndt Rolf and Christoph Ehlers in 2006 and is headquartered in Rostock, Denmark.
XXII - 22nd Century Group Inc - Stock Price Chart
TickerXXII [NASD]
Company22nd Century Group Inc
CountryUSA
IndustryTobacco
Market Cap11.34MEPS (ttm)-102.71
P/E-EPS this Y82.97%
Forward P/E-EPS next Y23.39%
PEG-EPS past 5Y-49.91%
P/S0.21EPS next 5Y-
P/B-EPS Q/Q85.43%
Dividend-Sales Q/Q-70.54%
Insider Own0.00%Inst Own6.42%
Insider Trans-Inst Trans-
Short Float1.14%EarningsMay 15/b
Analyst Recom2.00Target Price53.28
Avg Volume1.53M52W Range1.45 - 170.40
22nd Century Group, Inc. is a biotechnology company, which engages in the business of tobacco harm reduction, reduced nicotine tobacco, and improvement of health and wellness through plant science. It operates through the Tobacco and Hemp/Cannabis segments. The Tobacco segment manufactures branded filtered cigars and cigarettes. The Hemp/Cannabis segment focuses on the bulk ingredient distillate or isolate. The company was founded on September 12, 2005 and is headquartered in Buffalo, NY.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Arno AndrewDirectorJan 05 '24Buy0.17100,00017,490100,000Jan 08 08:04 PM
FIRESTONE LAWRENCEChief Executive OfficerJan 04 '24Buy0.17100,00017,360100,000Jan 05 04:32 PM
SHLS - Shoals Technologies Group Inc - Stock Price Chart
TickerSHLS [NASD, RUT]
CompanyShoals Technologies Group Inc
CountryUSA
IndustrySolar
Market Cap1.11BEPS (ttm)0.18
P/E36.29EPS this Y-16.61%
Forward P/E8.96EPS next Y33.59%
PEG2.84EPS past 5Y19.43%
P/S2.33EPS next 5Y12.80%
P/B1.99EPS Q/Q-71.19%
Dividend-Sales Q/Q-13.59%
Insider Own3.70%Inst Own118.14%
Insider Trans-0.28%Inst Trans-7.55%
Short Float13.77%EarningsMay 07/a
Analyst Recom1.67Target Price13.70
Avg Volume4.50M52W Range6.66 - 28.34
Shoals Technologies Group, Inc. provides electrical balance of system solutions for solar energy projects. Its EBOS components include cable assemblies, inline fuses, combiners, disconnects, recombiners, wireless monitoring systems, junction boxes, transition enclosures and splice boxes. The company was founded by Dean Solon in November 1996 and is headquartered in Portland, TN.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Peetz MehganGeneral CounselMar 08 '24Sale13.043,16041,206105,201Mar 11 04:37 PM
TOLNAR JEFFERYPresidentMar 08 '24Sale13.042,75035,86096,391Mar 11 04:37 PM
Lund InezChief Accounting OfficerMar 08 '24Sale13.051,94025,31721,577Mar 11 04:37 PM
Bardos DominicChief Financial OfficerDec 05 '23Sale14.244,20059,80866,925Dec 06 04:28 PM
Peetz MehganGeneral CounselDec 05 '23Sale14.213,31047,03578,075Dec 06 04:29 PM
HSDT - Helius Medical Technologies Inc - Stock Price Chart
TickerHSDT [NASD]
CompanyHelius Medical Technologies Inc
CountryUSA
IndustryMedical Devices
Market Cap3.72MEPS (ttm)-12.96
P/E-EPS this Y62.43%
Forward P/E-EPS next Y44.97%
PEG-EPS past 5Y63.34%
P/S5.55EPS next 5Y-
P/B0.66EPS Q/Q30.36%
Dividend-Sales Q/Q21.62%
Insider Own4.61%Inst Own3.02%
Insider Trans8.37%Inst Trans-
Short Float2.66%EarningsMay 13/a
Analyst Recom1.00Target Price4.00
Avg Volume541.45K52W Range1.49 - 14.44
Helius Medical Technologies, Inc. is a neurotech company in the medical device industry that focuses on neurological wellness. The firm develops, licenses and acquires non-invasive platform technologies that amplify the brain's ability to heal itself and reduce symptoms of neurological disease or trauma. It engages in the development of the investigational portable neuromodulation stimulator, that delivers neurostimulation via the tongue which has been shown in clinical studies to enhance the effectiveness of physical exercises in people with neurological symptoms from disease or trauma such as mild-to-moderate traumatic brain injury. The company was founded in 2014 and is headquartered in Newtown, PA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
ANDREEFF DANEPresident and CEODec 14 '23Buy8.105,00040,47516,512Dec 15 07:00 AM
ANDREEFF DANEPresident and CEODec 01 '23Buy6.452,00612,93513,685Dec 04 08:30 AM
ANDREEFF DANEPresident and CEONov 30 '23Buy6.372,00012,74112,551Dec 04 08:30 AM
ANDREEFF DANEPresident and CEOAug 30 '23Buy7.645,00038,21211,420Aug 30 08:42 PM
ANDREEFF DANEPresident and CEOAug 28 '23Buy6.375,07832,3398,774Aug 30 08:42 PM
1234567